Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,815 across all filing types
Latest filing 2025-12-01 Director's Dealing
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions by persons discharging managerial responsibilities (PDMRs), specifically members of the Board of Directors at Genmab A/S. It explicitly cites Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which is the standard regulatory framework for reporting insider/director dealings. The content details the acquisition of shares due to the vesting of restricted stock units for specific directors. This aligns perfectly with the 'Director's Dealing' (DIRS) category.
2025-12-01 English
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Director's Dealing Classification · 1% confidence The document is titled 'Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons'. It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which governs the disclosure of insider/director dealings. While the document mentions an attachment, the core purpose of the text is to report these specific transactions by managerial employees, which aligns perfectly with the 'Director's Dealing' (DIRS) category.
2025-12-01 Danish
6-K
Foreign Filer Report
2025-11-26 English
6-K
Foreign Filer Report
2025-11-20 English
6-K
Foreign Filer Report
2025-11-19 English
Regulatory Filings 2025
Regulatory Filings
2025-11-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.